nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.245	0.289	CbGbCtD
Ranitidine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.198	0.233	CbGbCtD
Ranitidine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.159	0.188	CbGbCtD
Ranitidine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.15	0.177	CbGbCtD
Ranitidine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0955	0.113	CbGbCtD
Ranitidine—Nephrotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.0121	0.0909	CcSEcCtD
Ranitidine—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.00907	0.068	CcSEcCtD
Ranitidine—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.00835	0.0626	CcSEcCtD
Ranitidine—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0081	0.0607	CcSEcCtD
Ranitidine—SLC22A8—nephron—focal segmental glomerulosclerosis	0.00728	0.388	CbGeAlD
Ranitidine—Nephropathy toxic—Cyclosporine—focal segmental glomerulosclerosis	0.00671	0.0503	CcSEcCtD
Ranitidine—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00627	0.047	CcSEcCtD
Ranitidine—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.0289	CcSEcCtD
Ranitidine—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00345	0.0259	CcSEcCtD
Ranitidine—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.0233	CcSEcCtD
Ranitidine—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.0197	CcSEcCtD
Ranitidine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.0192	CcSEcCtD
Ranitidine—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.019	CcSEcCtD
Ranitidine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.0181	CcSEcCtD
Ranitidine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0178	CcSEcCtD
Ranitidine—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.0178	CcSEcCtD
Ranitidine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.0174	CcSEcCtD
Ranitidine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.0164	CcSEcCtD
Ranitidine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.0163	CcSEcCtD
Ranitidine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.0158	CcSEcCtD
Ranitidine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.0145	CcSEcCtD
Ranitidine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.013	CcSEcCtD
Ranitidine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.0128	CcSEcCtD
Ranitidine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.0119	CcSEcCtD
Ranitidine—SLC22A8—nephron tubule—focal segmental glomerulosclerosis	0.00157	0.0837	CbGeAlD
Ranitidine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0117	CcSEcCtD
Ranitidine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0117	CcSEcCtD
Ranitidine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0116	CcSEcCtD
Ranitidine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0115	CcSEcCtD
Ranitidine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0114	CcSEcCtD
Ranitidine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.0114	CcSEcCtD
Ranitidine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.0113	CcSEcCtD
Ranitidine—SLC22A1—kidney—focal segmental glomerulosclerosis	0.0015	0.08	CbGeAlD
Ranitidine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0108	CcSEcCtD
Ranitidine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0108	CcSEcCtD
Ranitidine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0108	CcSEcCtD
Ranitidine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.0106	CcSEcCtD
Ranitidine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0104	CcSEcCtD
Ranitidine—SLC22A8—kidney—focal segmental glomerulosclerosis	0.00138	0.0735	CbGeAlD
Ranitidine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.0103	CcSEcCtD
Ranitidine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.0101	CcSEcCtD
Ranitidine—SLC22A8—cortex of kidney—focal segmental glomerulosclerosis	0.00135	0.0716	CbGeAlD
Ranitidine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00997	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00939	CcSEcCtD
Ranitidine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00933	CcSEcCtD
Ranitidine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00919	CcSEcCtD
Ranitidine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00917	CcSEcCtD
Ranitidine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00882	CcSEcCtD
Ranitidine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00882	CcSEcCtD
Ranitidine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0085	CcSEcCtD
Ranitidine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00819	CcSEcCtD
Ranitidine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00815	CcSEcCtD
Ranitidine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00815	CcSEcCtD
Ranitidine—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00104	0.0553	CbGeAlD
Ranitidine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0076	CcSEcCtD
Ranitidine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000973	0.00729	CcSEcCtD
Ranitidine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000941	0.00705	CcSEcCtD
Ranitidine—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000912	0.0486	CbGeAlD
Ranitidine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00091	0.00682	CcSEcCtD
Ranitidine—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000889	0.0473	CbGeAlD
Ranitidine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000875	0.00656	CcSEcCtD
Ranitidine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000868	0.0065	CcSEcCtD
Ranitidine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000867	0.00649	CcSEcCtD
Ranitidine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000862	0.00646	CcSEcCtD
Ranitidine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000817	0.00612	CcSEcCtD
Ranitidine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000685	0.0365	CbGeAlD
Ranitidine—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000674	0.0359	CbGeAlD
Ranitidine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000551	0.0294	CbGeAlD
Ranitidine—ABCB1—kidney—focal segmental glomerulosclerosis	0.000485	0.0258	CbGeAlD
Ranitidine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000472	0.0251	CbGeAlD
